The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses

The global generics market grew at a faster pace than the global pharma market in 2007, with a CAGR of 16.4% during 2004–2007. Regular patent expirations of blockbuster drugs are the primary growth driver of the industry. Rising healthcare expenditure has also contributed to industry expansion, with governments coming under growing pressure to provide low cost alternatives to branded drugs.

However, the generics market is changing due to the threat from authorized generics, competition from players in emerging countries and increasing consolidation. Teva’s acquisition of Barr Pharmaceuticals is the latest example of companies attempting to improve their market strength and geographical reach via divestments and acquisitions. ‘The Top 10 Generic Pharmaceutical Companies’ is a new report published by Business Insights that analyzes the size, structure and competitive landscape of the global generics market. The top 10 generics companies are assessed based on their market shares, product performances, therapeutic focus and future outlook, and the key issues and challenges facing these companies are examined. The latest industrial trends and developments are assessed across the generics markets of the UK, France, Germany, Italy, Spain and the US. This report also evaluates the strengths and weaknesses of the leading players and provides insights into the opportunities and threats that face them. Assess the structure, competitive landscape and latest developments in the global generics market, compare the performances and portfolios of leading companies and benchmark their strategies with this report. Compare the performances and growth strategies of leading generics companies and discover the business models that hold the key to future growth with this report.

Read more...

• Jacobsen Pharma A/S (20/07/2010)
• Authorized Generic Pharmaceuticals (29/06/2010)
• Depression (28/06/2010)

• PharmaVitae (10/10/2008)
• Bayer Schering Pharma AG (10/10/2008)
• Wyeth (10/10/2008)
• Johnson & Johnson (10/10/2008)
• AstraZeneca plc (10/10/2008)
• Schering-Plough Corporation (09/10/2008)
• Amgen Inc. (09/10/2008)
• Novo Nordisk A/S (09/10/2008)
• Bristol-Myers Squibb Co. (09/10/2008)

---